TORONTO, ON / ACCESSWIRE / April 25, 2023 / CANAQUEST MEDICAL CORP. (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.TORONTO, ON / ACCESSWIRE / December 8
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.